Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb;188(4):494-500.
doi: 10.1111/bjh.16278. Epub 2019 Nov 27.

Emergencies in haematology: tumour lysis syndrome

Urshila Durani  1 , William J Hogan  1
Affiliations
Review

Emergencies in haematology: tumour lysis syndrome

Urshila Durani et al. Br J Haematol. 2020 Feb.

Abstract

Tumour lysis syndrome (TLS) is a significant complication of haematologic malignancies and their management. The syndrome consists of laboratory abnormalities either alone (laboratory TLS) or with clinical sequelae including renal failure, seizures, and arrhythmias (clinical TLS). Clinical TLS is a predictor for worse overall morbidity and mortality in cancer patients, but can be prevented. Thus, accurate prognostication is critical to appropriate management of patients at risk for TLS, and incorporates both disease factors (tumour type and burden) and patient factors (baseline renal insufficiency or hyperuricaemia). Strategies to prevent TLS include hydration and allopurinol in low- and intermediate-risk patients and rasburicase in high-risk patients.

Keywords: leukemia; lymphoma; renal failure; tumor lysis syndrome.

PubMed Disclaimer

References

    1. AbbVie Inc. (2018) Venclexta (venetoclax) [package insert]. U.S. Food and Drug Administration website. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208573s009lbl.pdf.
    1. Andreoli, S.P., Clark, J.H., McGuire, W.A. & Bergstein, J.M. (1986) Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: Relationship to acute renal failure. The Journal of Pediatrics, 109, 292-298.
    1. Baeksgaard, L. & Sorensen, J.B. (2003) Acute tumor lysis syndrome in solid tumors-a case report and review of the literature. Cancer Chemotherapy and Pharmacology, 51, 187-92.
    1. Baudon, C., Duhoux, F.P., Sinapi, I. & Canon, J.L. (2016) Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report. Journal of Medical Case Reports, 10, 178.
    1. Bosly, A., Sonet, A., Pinkerton, C.R., McCowage, G., Bron, D., Sanz, M.A. & van den Berg, H. (2003) Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study. Cancer, 98, 1048-54.

LinkOut - more resources